TIGIT and neoplasm: Expanded NK cells were found to be more resistant to TIGIT inhibition, where TIGIT blockade did not increase the anti-tumor activities of PM21-NK cells against K562 cells or lung cancer cells in monolayers, or within the first 24–32 h of spheroid exposure.